Nurix Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 8.77 M | $212.77 M | -1.74% | 7.90% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 8.05 M | $195.29 M | 23.85% | 7.25% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 7.74 M | $187.69 M | 21.93% | 6.96% |
| RUBRIC CAPITAL MANAGEMENT LP | 08/14/2026 | 7.23 M | $175.35 M | 192.16% | 6.51% |
| FMR LLC | 08/13/2026 | 5.49 M | $133.07 M | -1.01% | 4.94% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 5.44 M | $131.89 M | 65.23% | 4.89% |
| MORGAN STANLEY | 08/13/2026 | 4.76 M | $115.54 M | -3.44% | 4.29% |
| STATE STREET CORP | 08/07/2026 | 4.68 M | $113.47 M | -9.02% | 4.21% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 4.66 M | $113.02 M | 0.00% | 4.19% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.50 M | $109.06 M | 1.55% | 4.05% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 4.32 M | $104.81 M | 16.43% | 3.89% |
| REDMILE GROUP, LLC | 08/14/2026 | 4.07 M | $98.83 M | -47.32% | 3.67% |
| GENERAL ATLANTIC, L.P. | 08/14/2026 | 3.03 M | $73.56 M | -26.08% | 2.73% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.54 M | $61.57 M | 0.68% | 2.28% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 2.35 M | $57.04 M | -13.75% | 2.12% |
| ARK INVESTMENT MANAGEMENT LLC | 08/14/2026 | 1.79 M | $43.50 M | 4.19% | 1.61% |
| CAPITAL WORLD INVESTORS | 08/12/2026 | 1.79 M | $43.37 M | 100.14% | 1.61% |
| TRAILS EDGE CAPITAL PARTNERS, LP | 08/14/2026 | 1.57 M | $38.17 M | -9.75% | 1.42% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 1.48 M | $35.97 M | 34.53% | 1.33% |
| CITADEL ADVISORS LLC | 09/02/2026 | 1.48 M | $35.83 M | 9.92% | 1.33% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 1.47 M | $35.54 M | 56.17% | 1.32% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.43 M | $34.72 M | 83.34% | 1.29% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/14/2026 | 1.30 M | $31.49 M | 0.00% | 1.17% |
| BRAIDWELL LP | 08/14/2026 | 1.29 M | $31.22 M | -26.50% | 1.16% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2026 | 1.19 M | $28.98 M | 0.00% | 1.08% |
| WOODLINE PARTNERS LP | 08/14/2026 | 1.06 M | $25.81 M | 14.97% | 0.96% |
| SUMITOMO MITSUI TRUST GROUP, INC. | 07/30/2026 | 983.46 K | $23.86 M | -16.74% | 0.89% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 08/13/2026 | 983.46 K | $23.85 M | -16.74% | 0.89% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 967.62 K | $23.47 M | 0.00% | 0.87% |
| UBS GROUP AG | 08/13/2026 | 917.12 K | $22.25 M | -6.07% | 0.83% |
| NORTHERN TRUST CORP | 08/13/2026 | 876.07 K | $21.25 M | 2.53% | 0.79% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 842.09 K | $20.43 M | 4.98% | 0.76% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 833.30 K | $20.22 M | -9.82% | 0.75% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 833.30 K | $20.22 M | 100.00% | 0.75% |
| NUVEEN, LLC | 08/11/2026 | 825.83 K | $20.03 M | 1.63% | 0.74% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 813.59 K | $19.74 M | -38.30% | 0.73% |
| KENNEDY CAPITAL MANAGEMENT LLC | 08/14/2026 | 724.51 K | $17.58 M | 29.09% | 0.65% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 686.34 K | $16.65 M | 8.56% | 0.62% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 08/13/2026 | 684.25 K | $16.60 M | 118.26% | 0.62% |
| HANDELSBANKEN FONDER AB | 07/10/2026 | 633.00 K | $15.36 M | 15.72% | 0.57% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 593.26 K | $14.39 M | 67.71% | 0.53% |
| SOFINNOVA INVESTMENTS, INC. | 08/14/2026 | 524.10 K | $12.71 M | 100.00% | 0.47% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 477.14 K | $11.58 M | 100.00% | 0.43% |
| ELMIND CAPITAL, LP | 08/14/2026 | 460.00 K | $11.16 M | 0.00% | 0.41% |
| CITIGROUP INC | 08/03/2026 | 389.38 K | $9.45 M | -18.44% | 0.35% |
| CANDRIAM S.C.A. | 08/13/2026 | 377.90 K | $9.16 M | -29.27% | 0.34% |
| FISHER ASSET MANAGEMENT, LLC | 08/04/2026 | 369.47 K | $8.96 M | -3.99% | 0.33% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2026 | 363.60 K | $8.82 M | -41.43% | 0.33% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 360.85 K | $8.75 M | 100.00% | 0.32% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 340.58 K | $8.26 M | 52.48% | 0.31% |
Nurix Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 275 institutional investors and hedge funds held shares of Nurix Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 8.77 M
Vestal Point Capital, LP: 8.05 M
Deep Track Capital, LP: 7.74 M
Rubric Capital Management LP: 7.23 M
FMR LLC: 5.49 M
PRICE T ROWE ASSOCIATES INC /MD/: 5.44 M
106.31% of Nurix Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 141.41 M shares in the last 24 months. This purchase volume represents approximately $2.19 B in transactions.